Erratum: Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5

PDF  |  How to cite

Oncotarget. 2018; 9:35196-35196. https://doi.org/10.18632/oncotarget.26241

Metrics: PDF 1254 views  |   ?  

Huabo Wang1, Jay Chauhan2, Angela Hu1, Kelsey Pendleton1, Jeremy L. Yap2, Philip E. Sabato3, Jace W. Jones2, Mariarita Perri4, Jianshi Yu2, Erika Cione4, Maureen A. Kane2,5, Steven Fletcher2,5 and Edward V. Prochownik1,6,7

1 Section of Hematology/Oncology, Children’s Hospital of Pittsburgh of UPMC
2 Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA
3 PharmD Program, University of Maryland School of Pharmacy, Baltimore, MD, USA
4 Department of Pharmaco-Biology, University of Calabria, Rende (CS), Italy
5 University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD, USA
6 Department of Microbiology and Molecular Genetics, The University of Pittsburgh School of Medicine
7 The University of Pittsburgh Cancer Institute, Pittsburgh, PA

Published: October 12, 2018

This article has been corrected: During production, the ending page number for this article was listed incorrectly. The page count has now been adjusted to show the proper pagination.

Original article: Oncotarget. 2013; 4:936-947. DOI: https://doi.org/10.18632/oncotarget.1108.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26241